MicThera

Zürich, Switzerland

MicThera is a biotech company that develops microbial derived therapeutics to provide effective treatments for prostate cancer patients.

$1.1M raised

May 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MicThera raised?

MicThera has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in May 2024.

Who are MicThera's investors?

MicThera's investors include Indaco Venture Partners.

Where is MicThera headquartered?

MicThera is headquartered in Zürich, Switzerland.

What does MicThera do?

MicThera is a biotech company that develops microbial derived therapeutics to provide effective treatments for prostate cancer patients.

What stage is MicThera at?

MicThera is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 30, 2024.

MLA

"MicThera — Funding & Investors." VCBacked, May 30, 2024, https://www.vcbacked.co/company/micthera. Accessed July 1, 2026.

APA

VCBacked. (2024). MicThera — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/micthera

Wikipedia (cite web)

{{cite web |title=MicThera — Funding & Investors |url=https://www.vcbacked.co/company/micthera |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 30, 2024.